Inhaltsbereich
| 169 Einträge | 1, 2, 3, 4, 5, 6, 7, 8, 9 › » |
Seite 1 / 9
 Druckansicht
|
| Effects of cilengitide in osteoclast maturation and behavior. |
| Chillà A, Bianconi D, Geetha N, Dorda A, Poettler M, Unseld M, Sykoutri D, Redlich K, Zielinski CC, Prager GW |
| Experimental cell research. 2015 Jul 21. pii: S0014-4827(15)30048-3. doi: 10.1016/j.yexcr.2015.07.018 |
| PMID: 26209605 |
| PTEN expression in endothelial cells is down-regulated by uPAR to promote angiogenesis. |
| Unseld M, Chilla A, Pausz C, Mawas R, Breuss J, Zielinski C, Schabbauer G, Prager GW |
| Thrombosis and haemostasis. 2015 Apr 30. pii: 15-01-0016. doi: 10.1160/TH15-01-0016 |
| PMID: 25925849 |
| Hedgehog inhibition reduces angiogenesis by downregulation of tumoral VEGF-A expression in hepatocellular carcinoma. |
| Pinter M, Sieghart W, Schmid M, Dauser B, Prager G, Dienes HP, Trauner M, Peck-Radosavljevic M |
| United European gastroenterology journal. 2014 Jun 11. doi: 10.1177/2050640613496605. pii: 10.1177_2050640613496605. pmc: PMC4040790 |
| PMID: 24917971 |
| Baseline carcinoembryonic antigen (CEA) serum levels predict bevacizumab-based treatment response in metastatic colorectal cancer. |
| Prager GW, Braemswig KH, Martel A, Unseld M, Heinze G, Brodowicz T, Scheithauer W, Kornek G, Zielinski CC |
| Cancer science. 2014 Jul 31. doi: 10.1111/cas.12451 |
| PMID: 24850362 |
| CD98hc (SLC3A2) drives integrin-dependent renal cancer cell behavior. |
| Poettler M, Unseld M, Braemswig K, Haitel A, Zielinski CC, Prager GW |
| Molecular cancer. 2013 Dec 21. pii: 1476-4598-12-169. doi: 10.1186/1476-4598-12-169. pmc: PMC3879186 |
| PMID: 24359579 |
| Soluble carcinoembryonic antigen activates endothelial cells and tumor angiogenesis. |
| Bramswig KH, Poettler M, Unseld M, Wrba F, Uhrin P, Zimmermann W, Zielinski CC, Prager GW |
| Cancer research. 2013 Oct 11. pii: 0008-5472.CAN-13-0123. doi: 10.1158/0008-5472.CAN-13-0123 |
| PMID: 24121495 |
| The implementation of minimally-invasive esophagectomy does not impact short-term outcome in a high-volume center. |
| Schwameis K, Ba-Ssalamah A, Wrba F, Birner P, Prager G, Hejna M, Schmid R, Asari R, Zacherl J, Schoppmann SF |
| Anticancer research. 2013 May 6. pii: 33/5/2085 |
| PMID: 23645759 |
| The urokinase receptor (CD87) represents a central mediator of growth factor-induced endothelial cell migration. |
| Poettler M, Unseld M, Mihaly-Bison J, Uhrin P, Koban F, Binder BR, Zielinski CC, Prager GW |
| Thrombosis and haemostasis. 2012 Jul 10. pii: 11-12-0868. doi: 10.1160/TH11-12-0868 |
| PMID: 22782499 |
| Erlotinib and sorafenib in an orthotopic rat model of hepatocellular carcinoma. |
| Sieghart W, Pinter M, Dauser B, Rohr-Udilova N, Piguet AC, Prager G, Hayden H, Dienes HP, Dufour JF, Peck-Radosavljevic M |
| Journal of hepatology. 2012 May 24. pii: S0168-8278(12)00364-9. doi: 10.1016/j.jhep.2012.04.034 |
| PMID: 22634341 |
| Angiogenesis in cancer: Anti-VEGF escape mechanisms. |
| Prager GW, Poettler M, Unseld M, Zielinski CC |
| Translational lung cancer research. 2015 Mar 25. doi: 10.3978/j.issn.2218-6751.2011.11.02. pii: tlcr-01-01-014. pmc: PMC4367591 |
| PMID: 25806151 |
| Angiogenesis in cancer. Basic mechanisms and therapeutic advances. |
| Prager GW, Poettler M |
| Hämostaseologie. 2011 Aug 12. pii: 1163. doi: 10.5482/ha-1163 |
| PMID: 21837355 |
| Targeting of VEGF-dependent transendothelial migration of cancer cells by bevacizumab. |
| Prager GW, Lackner EM, Krauth MT, Unseld M, Poettler M, Laffer S, Cerny-Reiterer S, Lamm W, Kornek GV, Binder BR, Zielinski CC, Valent P |
| Molecular oncology. 2010 Jan 7. pii: S1574-7891(10)00003-7. doi: 10.1016/j.molonc.2010.01.002 |
| PMID: 20106729 |
| Temporary placement of self-expanding oesophageal stents as bridging for neo-adjuvant therapy. |
| Langer FB, Schoppmann SF, Prager G, Tomaselli F, Pluschnig U, Hejna M, Schmid R, Zacherl J |
| Annals of surgical oncology. 2009 Oct 27. doi: 10.1245/s10434-009-0760-6 |
| PMID: 19859771 |
| The value of protecting the longitudinal staple line with invaginating sutures during esophageal reconstruction by gastric tube pull-up. |
| Silberhumer GR, Györi G, Burghuber C, Neumayer C, Riegler M, Jakesz R, Prager G, Schoppmann SF, Zacherl J |
| Digestive surgery. 2009 Aug 29. pii: 000235825. doi: 10.1159/000235825 |
| PMID: 19729925 |
| Fifty-five minimally invasive Esophagectomies: a single centre experience. |
| Schoppmann SF, Prager G, Langer F, Riegler M, Fleischman E, Zacherl J |
| Anticancer research. 2009 Jul 14. pii: 29/7/2719 |
| PMID: 19596952 |
| Surgery for gastrointestinal stromal tumors of the stomach. |
| Silberhumer GR, Hufschmid M, Wrba F, Gyoeri G, Schoppmann S, Tribl B, Wenzl E, Prager G, Laengle F, Zacherl J |
| Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 2009 Apr 9. doi: 10.1007/s11605-009-0872-0 |
| PMID: 19357931 |
| CD98hc (SLC3A2), a novel marker in renal cell cancer. |
| Prager GW, Poettler M, Schmidinger M, Mazal PR, Susani M, Zielinski CC, Haitel A |
| European journal of clinical investigation. 2009 Mar 18. pii: ECI2096. doi: 10.1111/j.1365-2362.2009.02096.x |
| PMID: 19292886 |
| The combination of 5-fluorouracil, leukovorin, etoposide, and cisplatin (FLEP) in patients with metastatic esophageal cancer. A single-institution experience. |
| Jonak C, Raderer M, Zacherl J, Prager G, Troch M, Ba-Ssalamah A, Hejna M |
| Anticancer research. 2009 Feb 5. |
| PMID: 19192667 |
| Design and instrumentation of new devices for performing appendectomy at colonoscopy (with video). |
| Silberhumer GR, Birsan T, Noda W, Unger E, Mayr W, Lang S, Prager G, Gasche C |
| Gastrointestinal endoscopy. 2008 May 2. pii: S0016-5107(08)00229-0. doi: 10.1016/j.gie.2008.02.024 |
| PMID: 18455170 |
| Cytotoxic activity of camptothecin and paclitaxel in newly established continuous human medullary thyroid carcinoma cell lines. |
| Kaczirek K, Schindl M, Weinhäusel A, Scheuba C, Passler C, Prager G, Raderer M, Hamilton G, Mittlböck M, Siegl V, Pfragner R, Niederle B |
| The Journal of clinical endocrinology and metabolism. 2004 May 5. doi: 10.1210/jc.2003-031314 |
| PMID: 15126569 |
| 169 Einträge | 1, 2, 3, 4, 5, 6, 7, 8, 9 › » |
Seite 1 / 9
Druckansicht
|
Schnellinfo
-- Initiative Krebsforschung / Krebsforschungslauf
-- Cancer Care
-- Kliniken und Partner
-- CCC Cancer School
-- Young CCC
-- CCC Tumorboards
-- CCC Forschungscluster
-- CCC Units
-- CCC Platforms
-- SOPs / Leitlinien
-- Kontakt
-- Cancer Care
-- Kliniken und Partner
-- CCC Cancer School
-- Young CCC
-- CCC Tumorboards
-- CCC Forschungscluster
-- CCC Units
-- CCC Platforms
-- SOPs / Leitlinien
-- Kontakt
Featured
